Duke researchers: Single CRISPR treatment provides long-term benefits in mice
Researchers at Duke University have shown that a single systemic treatment using CRISPR genome editing technology can safely and stably correct a genetic disease for more than a year in mice, despite observed immune responses and alternative gene editing outcomes.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed